Chronic Physical Effects and Health Care Utilization in Long-Term Ovarian Germ Cell Tumor Survivors: A Gynecologic Oncology Group Study Enrichment based on molecular characteristics has emerged as an ...

NEW YORK--(BUSINESS WIRE)--Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, today introduced Medidata Balance ™, a new randomization and trial ...

A new approach to designing clinical trials -- so that patients' odds of getting the better-performing treatment improve -- may help increase the number of people who agree to take part in medical ...

ANN ARBOR, Mich. — It's a classic Catch-22: Medical researchers need to figure out if a promising new treatment is truly better than a current one, by randomly assigning half of a group of patients to ...